Cephalexin

Product NDC: 49364-110
11-digit product format: 493640110
Labeler code: 49364
Product ID: 49364-110_08d050e8-f5dc-4dca-bbef-833156e28729
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Cephalexin
Dosage form: CAPSULE
Route: ORAL
Labeler: Strategic Pharmaceutical Solutions, Inc. DBA VetSource
Application: ANDA065248
Marketing category: ANDA
Marketing start: 2010-11-09
Marketing end: 0000-00-00
Substance: CEPHALEXIN
Active strength: 250 mg/1
Pharmacologic classes: Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	49364-110		I	Inactivated by FDA	2026-08-03
excluded package	package	49364-110	49364-110-45	I	Inactivated by FDA	2026-08-03
excluded package	package	49364-110	49364-110-90	I	Inactivated by FDA	2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 66 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	49364-110-90	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	49364-110-45	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	49364-110-90	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	49364-110-45	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	49364-110-90	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	49364-110-45	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	49364-110-90	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	49364-110-45	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	49364-110-90	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	49364-110-45	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	49364-110-90	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	49364-110-45	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	49364-110-90	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	49364-110-45	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	49364-110-90	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	49364-110-45	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	49364-110-90	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	49364-110-45	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	49364-110-90	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	49364-110-45	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	49364-110-90	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	49364-110-45	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	49364-110-90	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	49364-110-45	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	49364-110-90	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	49364-110-45	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	49364-110-90	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	49364-110-45	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	49364-110-90	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	49364-110-45	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	49364-110-90	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	49364-110-45	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	49364-110-90	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	49364-110-45	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	49364-110-90	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	49364-110-45	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	49364-110-90	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	49364-110-45	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	49364-110-90	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	49364-110-45	`e2bbac7714bc…`	`27bdfed8d636…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A065248-001	CEPHALEXIN	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB		2005-06-28
A065248-002	CEPHALEXIN	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB		2005-06-28

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A065248-001	AB
A065248-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A065248-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-06-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065248-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-06-28	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065248-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-06-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065248-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-06-28	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065248-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-06-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065248-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-06-28	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065248-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-06-28	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065248-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-06-28	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065248-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-06-28	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065248-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-06-28	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065248-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-06-28	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065248-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-06-28	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065248-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-06-28	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065248-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-06-28	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065248-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-06-28	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065248-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-06-28	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065248-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-06-28	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065248-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-06-28	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065248-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-06-28	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065248-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-06-28	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065248-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-06-28	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065248-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-06-28	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065248-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-06-28	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065248-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-06-28	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065248-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-06-28	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065248-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-06-28	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065248-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-06-28	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A065248-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-06-28	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065248-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-06-28	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065248-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-06-28	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065248-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-06-28	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A065248-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-06-28	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065248-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-06-28	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065248-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-06-28	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065248-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-06-28	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065248-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-06-28	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065248-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-06-28	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A065248-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-06-28	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065248-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	2005-06-28	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A065248-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	2005-06-28	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A065248-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065248-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065248-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065248-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065248-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065248-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065248-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065248-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065248-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065248-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065248-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065248-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065248-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065248-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065248-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065248-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065248-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065248-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065248-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065248-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065248-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065248-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065248-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065248-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065248-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065248-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065248-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A065248-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065248-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065248-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065248-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A065248-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065248-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065248-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065248-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065248-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065248-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A065248-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065248-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A065248-002	AB	1	`782e0a99824c…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
dfa3f520-409c-432e-b6d3-9250d468c772	Product name	1	20250401
64bb7f1a-2c2e-4741-8301-dbfeda7239f6	Product name	1	20190628
398aa563-bb78-fe0f-46a8-757c40ef28bf	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
49364-110-45	2019-10-29	C162847	48780-1	960f7f55-d43c-8e05-e053-dbdaa90a074a	CEPHALEXIN CAPSULES, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsules, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
49364-110-90	2019-10-29	C162847	48780-1	960f7f55-d43c-8e05-e053-dbdaa90a074a	CEPHALEXIN CAPSULES, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsules, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
49364-110-45	Cephalexin	45 in 1 BOTTLE	CAPSULE	45		1
49364-110-90	Cephalexin	90 in 1 BOTTLE	CAPSULE	90		1

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CEPHALEXIN	ACTIVE INGREDIENT	OBN7UDS42Y	CEPHALEXIN CAPSULE [STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. DBA VETSOURCE]	1
CEPHALEXIN ANHYDROUS	ACTIVE MOIETY	5SFF1W6677	CEPHALEXIN CAPSULE [STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. DBA VETSOURCE]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CEPHALEXIN CAPSULE [STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. DBA VETSOURCE]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	CEPHALEXIN CAPSULE [STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. DBA VETSOURCE]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	CEPHALEXIN CAPSULE [STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. DBA VETSOURCE]	1
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	CEPHALEXIN CAPSULE [STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. DBA VETSOURCE]	1
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	CEPHALEXIN CAPSULE [STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. DBA VETSOURCE]	1
GELATIN	INACTIVE INGREDIENT	2G86QN327L	CEPHALEXIN CAPSULE [STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. DBA VETSOURCE]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CEPHALEXIN CAPSULE [STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. DBA VETSOURCE]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CEPHALEXIN CAPSULE [STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. DBA VETSOURCE]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
49364-110	CEPHALEXIN CAPSULE [STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. DBA VETSOURCE]	1	Legacy NDC, 2 package rows	20110222_de8d97fd-3a76-4019-a640-882066c25c19.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
OBN7UDS42Y	CEPHALEXIN	23325-78-2	CEPHALEXIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
309112	cephalexin 250 MG Oral Capsule	PSN	de8d97fd-3a76-4019-a640-882066c25c19	1
309114	cephalexin 500 MG Oral Capsule	PSN	de8d97fd-3a76-4019-a640-882066c25c19	1
309112	cephalexin 250 MG Oral Capsule	SCD	de8d97fd-3a76-4019-a640-882066c25c19	1
309114	cephalexin 500 MG Oral Capsule	SCD	de8d97fd-3a76-4019-a640-882066c25c19	1
309114	cefalexin (as cefalexin monohydrate) 500 MG Oral Capsule	SY	de8d97fd-3a76-4019-a640-882066c25c19	1
309112	cephalexin (as cephalexin monohydrate) 250 MG Oral Capsule	SY	de8d97fd-3a76-4019-a640-882066c25c19	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
49364-110-45	49364011045	45 in 1 BOTTLE	Historical
49364-110-90	49364011090	90 in 1 BOTTLE	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Cephalexin	Strategic Pharmaceutical Solutions, Inc. DBA VetSource	2010-11-09	HUMAN PRESCRIPTION DRUG LABEL	1